Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
42 participants
OBSERVATIONAL
2024-10-02
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
FASt Track in Elective Neurosurgery: the Role of Low Propofol Bis-NOL Guided General Anaesthesia for Full, Early and Safe Awakening
NCT06844838
Mean Arterial Pressure Reduction Anesthesia Induction Using Propofol Bolus or Tritiated Target-infusion
NCT04291794
Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM
NCT06382467
Comparison of Different Propofol Formulations With or Without Remifentanil
NCT01592162
Is Anesthetic Loss of Consciousness a Top Down or Bottom up Phenomenon. What Does the Neurologic Examination Say?.
NCT03140982
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known sensitivity or allergy to propofol or remifentanil
* Patient participating in research for which a period of exclusion is currently required by other study protocol, ethical committee or health authority.
* Age \< 18 years old
* Patients subjected to infusion of propofol and/or remifentanil not delivered through TCI pumps before the inclusion
* Patients exposed to other sedatives (benzodiazepines, volatile anesthetics, quetiapine) before the inclusion
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Groningen
OTHER
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michele Introna, M.d.
Role: PRINCIPAL_INVESTIGATOR
Fondazione IRCCS Istituto Neurologico C. Besta
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foundation IRCCS Carlo Besta Neurological Institute
Milan, Italy, Italy
Fondazione IRCCS Istituto Neurologico C. Besta
Milan, Milano, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMPARE ICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.